Advertisement
Advertisement
DERM
Journey Medical Corporation Common Stock
4.78
USDSponsored
-2.05
-30.00%
Mar 26, 15:59 UTC -4
Closed
After-Market
4.83
+0.05
+1.05%
DERM Earnings Reports
Positive Surprise Ratio
DERM beat 6 of 17 last estimates.
35%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q4 25 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Journey Medical Corporation Common Stock earnings per share and revenue
On Mar 25, 2026, DERM reported earnings of -0.04 USD per share (EPS) for Q4 25, beating the estimate of -0.05 USD, resulting in a 31.86% surprise. Revenue reached 16.08 million, compared to an expected 19.24 million, with a -16.42% difference.
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Theravance Biopharma, Inc.
Report Date
Mar 19, 2026 For Q4 25
Estimate
$1.24
Actual
$0.21
Surprise
-83.12%
Context Therapeutics Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
-$0.10
Actual
-$0.14
Surprise
-29.39%
Avalo Therapeutics, Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
-$1.49
Actual
-$1.12
Surprise
+24.33%
Surrozen, Inc. Common
Report Date
Mar 30, 2026 For Q4 25
Estimate
-$1.21
Actual
-Surprise
-
Achieve Life Sciences, Inc.
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.27
Actual
-$0.28
Surprise
-1.12%
Pyxis Oncology, Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
-$0.34
Actual
-$0.28
Surprise
+15.55%
Fractyl Health, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.18
Actual
$0.15
Surprise
+181.70%
NRX Pharmaceuticals, Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
$0.00
Actual
-$0.01
Surprise
-361.54%
electroCore, Inc. Common Stock
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.41
Actual
-$0.34
Surprise
+18.15%
Talphera, Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.06
Surprise
+26.47%
FAQ
What were Journey Medical Corporation Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Journey Medical Corporation Common Stock reported EPS of -$0.04, beating estimates by 31.86%, and revenue of $16.08M, -16.42% below expectations.
How did the market react to Journey Medical Corporation Common Stock's Q4 2025 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Journey Medical Corporation Common Stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Journey Medical Corporation Common Stock's next earnings report?
Based on --
analysts, Journey Medical Corporation Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement